Evidence map›Paper›PMID 41062541›Full record

ArticleScientific reports2025

Immunoendocrine network under conditions of diabetes-filariasis co-morbidity DMLF6.

Joy Manohar Sibi, Sugumar Shruthi, Viswanathan Mohan, Subash Babu, Vivekanandhan Aravindhan

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joy Manohar SibiDepartment of Genetics, Dr ALM PG IBMS, University of Madras, Taramani, Chennai, 600113, India.
Sugumar ShruthiDepartment of Genetics, Dr ALM PG IBMS, University of Madras, Taramani, Chennai, 600113, India.
Viswanathan MohanMadras Diabetes Research Foundation & Dr. Mohan's Diabetes Specialties Centre, IDF Centre of Excellence in Diabetes Care and ICMR Centre for Advanced Research on Diabetes, Chennai, India.
Subash BabuInternational Centre for Excellence for Research, NIRT (ICMR), Chennai, India.
Vivekanandhan AravindhanDepartment of Genetics, Dr ALM PG IBMS, University of Madras, Taramani, Chennai, 600113, India. cvaravindhan@gmail.com.

Funding

University Grants Commission UGC-SAP
6 · The paper itself

Abstract

Childhood exposure to filariasis can confer significant protection against diabetes which is called as "Metabolic Hygiene Hypothesis". However, the effect of diabetes on anti-filarial immunity is not much studied. In the present study, the role of diabetes on systemic anti-filarial immunity was elucidated. Plasma levels of innate immune cytokines, adaptive immune cytokines, chemokines, hormones and growth factors were quantified by ELISA; Lipid and protein peroxidation and nitrite levels were quantified by spectrophotometry; Peripheral Tregs and exhausted T-cells were quantified by flowcytometry; FoxP3 expression was quantified by qRT-PCR. Anti-filarial immunity was significantly associated with elevated levels of TNF-α, IL-6, IL-1β, IL-10, IL-1Ra, DEF-A1, IL-12, IFN-γ, IL-2, IL-33, IL-9, IL-23, IL-17, IL-8, IP-10, SDF-1, MCP-1 and RANTES and decreased levels of IL-27, IL-4, leptin and FGF-21. Lipid peroxidation, nitrite levels and exhausted T cells were also increased. Chronic diabetes significantly reduced IL-1β, IL-1Ra, DEF-A1 and IL-8 and lipid peroxidation, and increased VEGF levels in DM-LF group. Overall, diabetes was found to downregulate a few critical innate immune components, of anti-filarial immunity, that can promote chronic pathology in LF + subjects.

Indexed as

FilariasisAdultComorbidityCytokinesFemaleHumansImmunity, InnateMaleMiddle AgedT-Lymphocytes, RegulatoryCytokinesChemokinesCytokinesDiabetesFilariasisGrowth factorsHormones

Identifiers

PMID41062541
PMCPMC12508471

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.